Clinical Neuropsychology: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Neuropsychopharmacol Mental Health 2016, Vol 1(1): e101

Impact of Genomic Medicine on the Future of Neuropsychopharmacology

Ramón Cacabelos1,2*
1Camilo José Cela University, , Madrid, Spain
2EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, , Corunna, Spain
*Corresponding Author : Prof. Ramón Cacabelos, EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, 15165-Bergondo, Corunna, Spain, Tel: +34-981-780505, Email: rcacabelos@ucjc.edu, rcacabelos@euroespes.com

Received Date: Sep 14, 2015 / Accepted Date: Sep 15, 2015 / Published Date: Oct 01, 2015

Citation: Cacabelos R (2015) Impact of Genomic Medicine on the Future of Neuropsychopharmacology. J Neuropsychopharmacol Mental Health 1: e101.

Copyright: © 2015 Cacabelos R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top